A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Interim report January 1-June 30, 2014: Pharmaceutical development programs advancing as planned - successful share issue enables progress according to strategy

Highlights in January-June 2014: Herantis Pharma Group was formed through the merger of two Finnish pharmaceutical development companies on April…

Read More

Final results of the initial public offering of Herantis Pharma

Final results of the initial public offering of Herantis Pharma Herantis Pharma PlcCompany release 4 June 2014 at 4 p.m.…

Read More

Herantis Pharma successfully completes its initial public offering

Herantis Pharma successfully completes its initial public offering Herantis Pharma PlcCompany release 2 June 2014 at 9:00 a.m. Not for…

Read More

Investors

Herantis is planning to submit an application to have its shares listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.